LENALIDOMIDE and PNEUMONIA

Overview

PNEUMONIA is the #4 most commonly reported adverse reaction for LENALIDOMIDE, manufactured by Celgene Corporation. There are 18,405 FDA adverse event reports linking LENALIDOMIDE to PNEUMONIA. This represents approximately 3.3% of all 557,894 adverse event reports for this drug.

Patients taking LENALIDOMIDE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PNEUMONIA is moderately reported among LENALIDOMIDE users, representing a notable but not dominant share of adverse events.

Other Side Effects of LENALIDOMIDE

In addition to pneumonia, the following adverse reactions have been reported for LENALIDOMIDE:

• DIARRHOEA — 30,628 reports
• DEATH — 26,182 reports
• FATIGUE — 26,153 reports
• OFF LABEL USE — 18,216 reports
• RASH — 17,711 reports
• PLASMA CELL MYELOMA — 16,822 reports
• NEUROPATHY PERIPHERAL — 11,858 reports
• WHITE BLOOD CELL COUNT DECREASED — 11,646 reports
• CONSTIPATION — 10,846 reports
• NAUSEA — 10,622 reports

Other Drugs Associated with PNEUMONIA

The following drugs have also been linked to pneumonia in FDA adverse event reports:

Does LENALIDOMIDE cause PNEUMONIA?

PNEUMONIA has been reported as an adverse event in 18,405 FDA reports for LENALIDOMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PNEUMONIA with LENALIDOMIDE?

PNEUMONIA accounts for approximately 3.3% of all adverse event reports for LENALIDOMIDE, making it a notable side effect.

What should I do if I experience PNEUMONIA while taking LENALIDOMIDE?

If you experience pneumonia while taking LENALIDOMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages